Intellia Therapeutics Inc (NTLA)

NASDAQ · Biotechnology

11.21
+0.05 (+0.45%)
Updated Oct 24, 3:24 AM ET
AI Rating
Sell
Overall Score
31
Trend
11
Momentum
40
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 8, 2025 260 sessions Oct 20, 2026

AI Analysis

Intellia Therapeutics Inc is trading at $11.21, up 0.45% on the session. The 50 day average sits at $12.25 and the 200 day at $13.02, which puts the stock in a downtrend. RSI is at 47.7, which reads as neutral, and MACD is bearish crossover. Volume is below average.

The nearest support is around $11.70 with resistance near $12.31, so that band frames the current range. Average daily movement is roughly $0.74, or about 6.6% of the share price, which is what any stop placement has to allow for. The overall health score of 31 out of 100 combines a trend score of 11, momentum of 40 and a risk score of 52.

Technical indicators

RSI (14)
47.7
neutral
MACD
-0.154
bearish crossover
SMA 20
12.04
SMA 50
12.25
SMA 200
13.02
downtrend
ATR (14)
0.74
avg daily range
Support
11.70
Resistance
12.31
Volume vs 20d
0.57x
below average
Volatility
57.3%
annualised
1 month
-3.11%
3 months
+6.38%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.